logo
* 搜尋
* 核能資訊中心
* 中心簡介
* 相關資訊
* 瀏覽人數
今天: 117
昨天: 123
本月: 2345
總計: 539833
國際核能現況 : Bruce Power and ITM to supply cancer therapy isotope
發表人 nicenter 於 2018/7/2 10:40:05 (38 人讀取)

Bruce Power and ITM to supply cancer therapy isotope


Bruce Power and ITG, a subsidiary of radiopharmaceutical technology company ITM Isotopen Technologien München (ITM), have launched a joint effort to explore the production of the medical radioisotope lutetium-177 (Lu-177) at Bruce Power's Candu reactors.



Bruce-ITM_Lu-177_MOU_June18_(Bruce)-460

ITM's Mark Harfensteller, seated at left, signs the MoU with Bruce's James Scongack, front centre. Also shown are Bruce Power's Pat Dalzell at front right, with ITM's Ingo Russnak and Bruce Power's Kurt Wigle standing. (Image: Bruce Power)


Lu-177 is used in targeted radionuclide therapy to treat cancers like neuroendocrine tumours and prostate cancer. The medical-grade radioisotope is used to destroy cancer cells while leaving healthy cells unaffected.


The companies yesterday announced the signature of a Memorandum of Understanding to explore the production of Lu-177 at Bruce, which they say has the ability to meet global supply needs until 2064. The partnership aims to meet the medical community's growing demand for the radioisotope. Development, processing, and global distribution of Lu-177 will be managed by ITG.


Bruce's Candu units already produce cobalt-60, which is used for the sterilisation of medical equipment and in a specialised form of cancer treatment called the Gamma Knife. The company is part of the recently established Canadian Nuclear Isotope Council, which aims to develop collective solutions to maintain Canada's leadership position on the global isotope stage following the shut-down earlier this year of the National Research Universal reactor after over 60 years of operation.


Bruce Power in 2017 signed an agreement with Areva NP - now Orano - for Areva to design and supply equipment to be installed in the existing Bruce Candu units to add online production at commercial scale of a wide range of isotopes including short half-life isotopes such as Mo-99, Lu-177 and iridium-192 using a system that inserts and removes targets with little impact on the normal operation of the power reactors.


"Bruce Power is a world leader in the production of critical radioisotopes used to treat cancer," said Mike Rencheck, Bruce Power's president and CEO. "By developing innovative ways to generate these radioisotopes, we help ensure that the medical community has access to a reliable source of medical radioisotopes for Targeted Radionuclide Therapy."


Steffen Schuster, CEO of ITM, said: "With Bruce Power's long-term outlook to operate its facility through 2064 and its existing expertise with cobalt production, we have the opportunity to provide a stable source of lutetium-177 to cancer patients worldwide."


Researched and written
by World Nuclear News



source: http://www.world-nuclear-news.org/RS-Bruce-Power-and-ITM-to-supply-cancer-therapy-isotope-2906187.html



其他新聞
2018/9/19 9:50:17 - Centrus and Doosan sign advanced reactor MoU
2018/9/19 9:48:52 - French EPR engineering simulator to be upgraded
2018/9/19 9:47:20 - IAEA highlights nuclear's role in combating climate change
2018/9/19 9:45:28 - Challenging the nuclear finance status quo
2018/9/19 9:42:52 - Hualong One simulator ready for operator training
2018/9/17 9:35:44 - UK and USA enhance nuclear research cooperation
2018/9/17 9:33:05 - UK collaboration for safety and security research
2018/9/17 9:31:22 - Nuclear industry faces wake-up call, says IAEA's Chudakov
2018/9/17 9:26:43 - US plant operators prepare for Hurricane Florence
2018/9/14 9:39:51 - Newcomer countries need 'collaborative approach'
2018/9/14 9:36:42 - Investment needed to maintain nuclear's growth, says IAEA
2018/9/14 9:34:49 - Climate targets need market reform, says NEA's Magwood
2018/9/14 9:27:18 - India recommissions Apsara research reactor
2018/9/14 9:25:19 - California to be carbon neutral by 2045
2018/9/14 9:22:17 - 輻射監測更上層樓,蘭嶼氣象站標準型環境輻射監測設施啟用
2018/9/12 10:06:26 - Help the public understand radiation, advises cancer expert
2018/9/12 10:02:33 - Belgian government approves funding for Myrrha
2018/9/12 10:00:34 - IAEA completes Sudan nuclear infrastructure review
2018/9/12 9:58:46 - California to be carbon neutral by 2045
2018/9/12 9:49:01 - 原能會讓國人「石」在安心-持續執行107年石材建材業者輻射檢測

 線上期刊目錄

 友善連結

單位類

行政院原子能委員會
放射性物料管理局
核能研究所
國立清華大學工程與系統科學系
國立清華大學生醫工程與環境科學系
中華民國核能學會
財團法人核能科技協進會

新聞類


30013 新竹市光復路二段101號 創新育成中心三樓309室 電話:(03)571-1808 傳真:(03)572-5461 Email: nicenter@nicenter.org.tw